| Fibrinogen-like protein 1 is a major immune inhibitory ligand of LAG-3 J Wang, MF Sanmamed, I Datar, TT Su, L Ji, J Sun, L Chen, Y Chen, ... Cell 176 (1), 334-347. e12, 2019 | 686 | 2019 |
| Impaired HLA class I antigen processing and presentation as a mechanism of acquired resistance to immune checkpoint inhibitors in lung cancer S Gettinger, J Choi, K Hastings, A Truini, I Datar, R Sowell, A Wurtz, ... Cancer discovery 7 (12), 1420-1435, 2017 | 614 | 2017 |
| Expression analysis and significance of PD-1, LAG-3, and TIM-3 in human non–small cell lung cancer using spatially resolved and multiparametric single-cell analysis I Datar, MF Sanmamed, J Wang, BS Henick, J Choi, T Badri, W Dong, ... Clinical Cancer Research 25 (15), 4663-4673, 2019 | 261 | 2019 |
| Spatially resolved and quantitative analysis of VISTA/PD-1H as a novel immunotherapy target in human non–small cell lung cancer F Villarroel-Espindola, X Yu, I Datar, N Mani, M Sanmamed, V Velcheti, ... Clinical Cancer Research 24 (7), 1562-1573, 2018 | 179 | 2018 |
| A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers SN Gettinger, J Choi, N Mani, MF Sanmamed, I Datar, R Sowell, VY Du, ... Nature communications 9 (1), 3196, 2018 | 161 | 2018 |
| Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer ML de Rodas, V Nagineni, A Ravi, IJ Datar, M Mino-Kenudson, ... Journal for immunotherapy of cancer 10 (6), 2022 | 65 | 2022 |
| Epithelial–mesenchymal transition and immune evasion during lung cancer progression: The chicken or the egg? I Datar, KA Schalper Clinical Cancer Research 22 (14), 3422-3424, 2016 | 49 | 2016 |
| RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration I Datar, X Qiu, HZ Ma, M Yeung, S Aras, I de la Serna, F Al-Mulla, ... Oncotarget 6 (36), 39050, 2015 | 49 | 2015 |
| SWI/SNF enzymes promote SOX10-mediated activation of myelin gene expression HG Marathe, G Mehta, X Zhang, I Datar, A Mehrotra, KC Yeung, ... PLoS One 8 (7), e69037, 2013 | 42 | 2013 |
| RKIP inhibits local breast cancer invasion by antagonizing the transcriptional activation of MMP13 I Datar, J Feng, X Qiu, J Lewandowski, M Yeung, G Ren, S Aras, ... PloS one 10 (8), e0134494, 2015 | 36 | 2015 |
| Spatial analysis and clinical significance of HLA class-I and class-II subunit expression in non–small cell lung cancer IJ Datar, SC Hauc, S Desai, N Gianino, B Henick, Y Liu, K Syrigos, ... Clinical Cancer Research 27 (10), 2837-2847, 2021 | 19 | 2021 |
| Genetic and epigenetic control of RKIP transcription I Datar, H Tegegne, K Qin, F Al-Mulla, MS Bitar, RJ Trumbly, KC Yeung Critical Reviews™ in Oncogenesis 19 (6), 2014 | 12 | 2014 |
| MA15. 06 Predictive value of measuring somatic mutations and tumor infiltrating lymphocytes for PD-1 axis therapy in non-small cell lung cancer (NSCLC) S Gettinger, J Choi, N Mani, I Datar, E Kaftan, S Goldberg, D Zelterman, ... Journal of Thoracic Oncology 12 (1), S430-S431, 2017 | 9 | 2017 |
| A Micro-RNA Connection in-Mediated Premature Senescence of Human Melanocytes G Ren, J Feng, I Datar, AH Yeung, SV Saladi, Y Feng, I de la Serna, ... International journal of cell biology 2012, 2012 | 9 | 2012 |
| Critical role of miR-10b in B-RafV600E dependent anchorage independent growth and invasion of melanoma cells I Datar, G Kalpana, J Choi, T Basuroy, R Trumbly, SK Chaitanya Arudra, ... Plos one 14 (4), e0204387, 2019 | 6 | 2019 |
| Measurement of PD-1, TIM-3 and LAG-3 protein in non-small cell lung carcinomas (NSCLCs) with acquired resistance to PD-1 axis blockers. I Datar, N Mani, BS Henick, A Wurtz, E Kaftan, RS Herbst, DL Rimm, ... Journal of Clinical Oncology 35 (15_suppl), e14611-e14611, 2017 | 5 | 2017 |
| Correction: RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration I Datar, X Qiu, HZ Ma, M Yeung, S Aras, I De La Serna, F Al-Mulla, ... Oncotarget 7 (18), 26925, 2016 | 3 | 2016 |
| Quantitative tissue analysis and role of myeloid cells in non-small cell lung cancer BS Henick, F Villarroel-Espindola, I Datar, MF Sanmamed, J Yu, S Desai, ... Journal for Immunotherapy of Cancer 10 (7), 2022 | 2 | 2022 |
| In patients with advanced non-small cell lung cancer (NSCLC) LAG-3 is expressed on activated TILs and predicts resistance to PD-1 axis blockers I Datar, MF Sanmamed, J Choi, J Wang, BS Henick, T Badri, LD Mejias, ... Annals of Oncology 28, xi5, 2017 | 2 | 2017 |
| Multiplexed analysis of fixed tumor tissues using imaging mass cytometry F Villarroel-Espindola, D Carvajal-Hausdorf, I Datar, A Esch, N Rashidi, ... Cancer Research 77 (13_Supplement), 1635-1635, 2017 | 2 | 2017 |
